| Retina Research Unit |
|---|
| Drug Trial |
|---|
IQVIA- A Global, Phase III, Double Blind, Randomized Controlled Study to Compare the Efficacy, Safety & Immunogenicity of LUBT010 with Lucentis® in Patients with Neovascular Age-Related Macular Degeneration PI- Dr Asim Kumar Ghosh COI- Dr Sneha Jain, Dr. Soumyadeep Majumdar, Dr. Tania Ray Bhadra, Dr. Paridhi Todi, Dr. Shyamapada Biswas |
PPD- A phase III Randomized, Double-Masked, Parallel Group, Multicenter Study to Compare the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity between SCD411 and Eylea in Subjects with Neovascular Age-related Macular Degeneration PI- Dr Asim Kumar Ghosh COI- Dr Sneha Jain, Dr. Soumyadeep Majumdar, Dr. Tania Ray Bhadra, Dr. Paridhi Todi, Dr. Shyamapada Biswas |
SUN- A phase III, Comparative, Double Blind, Randomized, Multi-centric Study to compare the Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab with Reference Biologic in Patient with Neovascular Age-related Macular Degeneration (wet AMD).
PI- Dr Asim Kumar Ghosh COI- Dr. Tania Ray Bhadra
|
QILU- A Randomized, Phase 3, Double-masked, Parallel- group, Multicenter Study to Compare Efficacy and Safety of QLI205 Versus Lucentis in Subjects With Neovascular Age-related Macular Degeneration. PI- Dr. Krishnapada Baidya COI- Dr. Lakshmi Kanta Mondal, Dr. Devadri Basu , Dr. Paridhi Todi, Dr. Sneha Jain, Dr. Amrita Pal, Dr. Arindam Roy LAMBDA- "A Double Masked, Parallel Group, Randomized, Multicenter, Clinical Study to Compare Efficacy and Safety of IntasRanibizumab with Lucentis@ in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD)" PI- Dr. Lakshmi Kanta Mondal COI- Dr Sneha Jain, Dr. Tania Ray Bhadra, Dr. Paridhi Todi, Dr. Abhishek Chaudhuri |
| Research Activities related to Eye Bank |
|---|
